Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Jean-Louis Montastruc19
Antiparkinson Agents (therapeutic use)53
Jean-Louis Montastruc Sauf Antiparkinson Agents (therapeutic use)" 17
Antiparkinson Agents (therapeutic use) Sauf Jean-Louis Montastruc" 51
Jean-Louis Montastruc Et Antiparkinson Agents (therapeutic use) 2
Jean-Louis Montastruc Ou Antiparkinson Agents (therapeutic use) 70
Corpus679
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000312 Adeline Gallini [France] ; Agnès Sommet [France] ; Anne-Marie Salandini [France] ; Patrick Veyssière [France] ; Jean-Louis Montastruc [France] ; Jean-Louis Montastruc [France]Weight‐loss associated with anti‐dementia drugs in a patient with Parkinson's disease
000508 Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024